Correlation Between Exact Therapeutics and Nidaros Sparebank

Can any of the company-specific risk be diversified away by investing in both Exact Therapeutics and Nidaros Sparebank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exact Therapeutics and Nidaros Sparebank into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exact Therapeutics AS and Nidaros Sparebank, you can compare the effects of market volatilities on Exact Therapeutics and Nidaros Sparebank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exact Therapeutics with a short position of Nidaros Sparebank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exact Therapeutics and Nidaros Sparebank.

Diversification Opportunities for Exact Therapeutics and Nidaros Sparebank

-0.04

Correlation Coefficient

Exact Therapeutics  Nidaros Sparebank

Good diversification

The 3 months correlation between Exact and Nidaros is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Exact Therapeutics AS and Nidaros Sparebank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nidaros Sparebank and Exact Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exact Therapeutics AS are associated (or correlated) with Nidaros Sparebank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nidaros Sparebank has no effect on the direction of Exact Therapeutics i.e., Exact Therapeutics and Nidaros Sparebank go up and down completely randomly.

Pair Corralation between Exact Therapeutics and Nidaros Sparebank

Assuming the 90 days trading horizon Exact Therapeutics AS is expected to under-perform the Nidaros Sparebank. In addition to that, Exact Therapeutics is 3.18 times more volatile than Nidaros Sparebank. It trades about -0.01 of its total potential returns per unit of risk. Nidaros Sparebank is currently generating about 0.09 per unit of volatility. If you would invest  9,586  in Nidaros Sparebank on December 30, 2024 and sell it today you would earn a total of  1,010  from holding Nidaros Sparebank or generate 10.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Exact Therapeutics AS  vs.  Nidaros Sparebank

Exact Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Exact Therapeutics AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Exact Therapeutics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Nidaros Sparebank

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nidaros Sparebank are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, Nidaros Sparebank may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Exact Therapeutics and Nidaros Sparebank

The main advantage of trading using opposite Exact Therapeutics and Nidaros Sparebank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exact Therapeutics position performs unexpectedly, Nidaros Sparebank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nidaros Sparebank will offset losses from the drop in Nidaros Sparebank's long position.

The idea behind Exact Therapeutics AS and Nidaros Sparebank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.